Abstract: A pharmaceutically active composition containing an effective amount of a pharmacologically active ingredient such as an antifungal and a carrier. The carrier comprises dimethyl isosorbide, undecylenic acid, a lower carboxylic acid other than undecylenic acid, a monohydric alcohol having from 2 to 4 carbon atoms, and urea.
Abstract: A method for treating discoloration of nails comprising applying to the nails a composition containing undecylenic acid, a urea-based component, a monohydric alcohol such as isopropanol, a diol such as propylene glycol, dimethyl isosorbide, and a carboxylic acid other than undecylenic acid, preferably lactic acid.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
July 2, 2019
Assignee:
Marlinz Pharma, LLC
Inventors:
Perry Forrester, Joshua Scott, James Adkinson
Abstract: A composition suitable for topical application to the nails contains undecylenic acid, a urea-based component, a monohydric alcohol such as isopropanol, a diol such as propylene glycol, dimethyl isosorbide, and a carboxylic acid other than undecylenic acid, preferably lactic acid.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
April 16, 2019
Assignee:
Marlinz Pharma, LLC
Inventors:
Perry Forrester, Joshua Scott, James Adkinson
Abstract: A pharmaceutically active composition suitable for topical application to the nails contains undecylenic acid and tolnaftate. The composition also employs a urea-based component, a monohydric alcohol such as isopropanol, a diol such as propylene glycol, dimethyl isosorbide, and a carboxylic acid other than undecylenic acid, preferably lactic acid.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
April 9, 2019
Assignee:
Marlinz Pharma, LLC
Inventors:
Perry Forrester, Joshua Scott, James Adkinson
Abstract: A method of treating nail diseases by topically applying to the nails a composition containing undecylenic acid and tolnaftate, a urea-based component, a monohydric alcohol such as isopropanol, a diol such as propylene glycol, dimethyl isosorbide, and a carboxylic acid, preferably lactic acid.
Type:
Grant
Filed:
August 8, 2017
Date of Patent:
February 19, 2019
Assignee:
Marlinz Pharma, LLC
Inventors:
Perry Forrester, Joshua Scott, James Adkinson